News | Heart Failure | November 17, 2017

Surgery Could Reduce Frailty in Adults With Heart Failure

Patients showed a reduction in measures of frailty after left ventricular assist device (LVAD) surgery

Surgery Could Reduce Frailty in Adults With Heart Failure

November 17, 2017 — Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults, including those with heart failure. However, a number of indicators of frailty — such as weakness, low energy or decreased physical activity – can also be caused by heart failure. To tease apart whether frail patients might benefit from surgery to treat heart failure, researchers looked at whether the left ventricular-assist device (LVAD) surgery could improve measures of frailty and quality of life. They found that for some patients, it did, as early as three months after surgery.

“Surgery can carry greater risks for older, frail individuals, but we wanted to test whether the LVAD could reverse frailty and improve quality of life in these higher-risk patients,” said cardiologist Gordon Reeves, M.D., associate professor of cardiology at the Sydney Kimmel Medical College at Jefferson University. “Importantly, this study shows that frailty is modifiable, it can get better with interventions like the LVAD.” The results were published in the Journal of the American Geriatrics Society.

Reeves, together with colleagues at Columbia University, studied 29 older, frail patients with advanced heart failure who were eligible to receive an LVAD. The patients were enrolled from across five academic medical centers part of the Greater Geriatric Cardiology Consortium in a prospective pilot study. The researchers assessed patients on measures of frailty, quality of life, and cognition prior to performing LVAD surgery. The LVAD is a pump that is surgically implanted into the left ventricle of the heart, supplying blood to the rest of the body.

The researchers found that there was a significant improvement in frailty with LVAD surgery and that this continued through six months of observation after the surgery. However, despite this improvement, about half of patients remained frail. Changes in frailty were also associated with quality of life measures, so that patients whose frailty did not improve, also did not see any improvements in quality of life. “We don’t have enough data from this trial to be able to say which patients would benefit from LVAD versus those who won’t,” said Reeves.

“Although these results show that the LVAD procedure can decrease measure of frailty in some patients, we know that it does not completely reverse it,” said Reeves. “There are also a number of interventions, such as physical therapy and nutrition supplementation, that have shown promise in reducing frailty even further after LVAD surgery. This is an active area of research for us as well.”

For more information: www.onlinelibrary.wiley.com


Related Content

News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
News | Heart Failure

Jan. 6, 2026 — Millions of Americans living with heart failure are not receiving medications that have been proven for ...

Home January 10, 2026
Home
News | Heart Failure

Dec. 16,2025 — The European Society of Cardiology (ESC) has welcomed the adoption of the Safe Hearts Plan, a landmark ...

Home December 23, 2025
Home
News | Heart Failure

Dec. 18, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), has announced the ...

Home December 22, 2025
Home
News | Heart Failure

Dec. 18, 2025 – Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home December 18, 2025
Home
News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
Subscribe Now